This represents the biggest annual dollar amount disbursed since the Pancreatic Cancer Action Network introduced the planned program in 2003, and can be an almost 30 % increase in funding over this past year. The grants system is made to help incubate innovative research projects, grow the amount of researchers working on pancreatic cancer, nurture collaborations across establishments and disciplines, and expedite scientific improvement for patient benefit. In addition to receiving monetary support because of their research, grantees participate in a mentorship program that connects them with leading researchers in the field. Ongoing career support activities offer possibilities for education and professional development. ‘This year’s grants plan marks a substantial milestone as we will have surpassed $10 million in analysis funding because the program’s inception in 2003,’ stated Julie Fleshman, president and CEO of the Pancreatic Cancer Actions Network.Both of these are fast-developing ones and markets in which government and private sectors are trying to build features. Quintiles is normally well-positioned to support this growth. Related StoriesUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasRE.WORK showcases potential technology and improvements in deep learning softwareDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixQuintiles President and Head of Asia Pacific Anand Tharmaratnam said, This honor belongs to your 10,000 plus workers across Asia Pacific who have work every day to boost our customers' probability of success.